263 related articles for article (PubMed ID: 29433934)
21. The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department.
Rund DA; Ewing JD; Mitzel K; Votolato N
J Emerg Med; 2006 Oct; 31(3):317-24. PubMed ID: 16982374
[TBL] [Abstract][Full Text] [Related]
22. Sedation in acute and chronic agitation.
Levy RH
Pharmacotherapy; 1996; 16(6 Pt 2):152S-159S; discussion 166S-168S. PubMed ID: 8947999
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of ketamine versus haloperidol for severe prehospital agitation.
Cole JB; Moore JC; Nystrom PC; Orozco BS; Stellpflug SJ; Kornas RL; Fryza BJ; Steinberg LW; O'Brien-Lambert A; Bache-Wiig P; Engebretsen KM; Ho JD
Clin Toxicol (Phila); 2016 Aug; 54(7):556-62. PubMed ID: 27102743
[TBL] [Abstract][Full Text] [Related]
24. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
[TBL] [Abstract][Full Text] [Related]
25. Management of Acute Agitation and Aggression in Children and Adolescents with Pro Re Nata Oral Immediate Release Antipsychotics in the Pediatric Emergency Department.
Yip L; Aeng E; Elbe D
J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):534-541. PubMed ID: 33035069
[No Abstract] [Full Text] [Related]
26. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.
Bosanac P; Hollander Y; Castle D
Australas Psychiatry; 2013 Dec; 21(6):554-62. PubMed ID: 23996795
[TBL] [Abstract][Full Text] [Related]
27. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
28. Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval.
Ries R; Sayadipour A
J Psychiatr Pract; 2014 Sep; 20(5):338-44. PubMed ID: 25226194
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological treatment of psychotic agitation.
Currier GW; Trenton A
CNS Drugs; 2002; 16(4):219-28. PubMed ID: 11945106
[TBL] [Abstract][Full Text] [Related]
30. The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.
Bak M; Weltens I; Bervoets C; De Fruyt J; Samochowiec J; Fiorillo A; Sampogna G; Bienkowski P; Preuss WU; Misiak B; Frydecka D; Samochowiec A; Bak E; Drukker M; Dom G
Eur Psychiatry; 2019 Apr; 57():78-100. PubMed ID: 30721802
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological management of agitation in emergency settings.
Yildiz A; Sachs GS; Turgay A
Emerg Med J; 2003 Jul; 20(4):339-46. PubMed ID: 12835344
[TBL] [Abstract][Full Text] [Related]
33. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
34. Parenteral Antipsychotic Choice and Its Association With Emergency Department Length of Stay for Acute Agitation Secondary to Alcohol Intoxication.
Cole JB; Klein LR; Martel ML
Acad Emerg Med; 2019 Jan; 26(1):79-84. PubMed ID: 29851193
[TBL] [Abstract][Full Text] [Related]
35. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
[TBL] [Abstract][Full Text] [Related]
36. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.
Lim HK; Kim JJ; Pae CU; Lee CU; Lee C; Paik IH
Neuropsychobiology; 2010; 62(2):81-6. PubMed ID: 20523078
[TBL] [Abstract][Full Text] [Related]
37. Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.
Gonzalez D; Bienroth M; Curtis V; Debenham M; Jones S; Pitsi D; George M
Curr Med Res Opin; 2013 Mar; 29(3):241-50. PubMed ID: 23323879
[TBL] [Abstract][Full Text] [Related]
38. Approach to the Agitated Emergency Department Patient.
Gottlieb M; Long B; Koyfman A
J Emerg Med; 2018 Apr; 54(4):447-457. PubMed ID: 29395692
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation.
Duñó Ambròs R; Oliva Morera JC; Iglesias-Lepine ML; Palao Vidal D; Monreal Ortiz JAMO; Labad Arias J
Actas Esp Psiquiatr; 2021 Sep; 49(5):205-209. PubMed ID: 34533203
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological management of acutely agitated schizophrenic patients.
San L; Arranz B; Escobar R
Curr Pharm Des; 2005; 11(19):2471-7. PubMed ID: 16026300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
